BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

RxGen, Inc. 

100 Deepwood Drive

Hamden  Connecticut    U.S.A.
Phone: 203-498-9706 Fax: 203-7762893


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Iris Pharma and RxGen, Inc. Announce Strategic Alliance 4/19/2012 9:46:28 AM    More...
RxGen, Inc. and miRagen Therapeutics Announce Award of National Institutes of Health (NIH)-National Heart, Lung, and Blood Institute SBIR Grant to Fund Advanced Preclinical Studies Evaluating the Role of microRNAs in Cardiac Disease 8/25/2011 10:34:52 AM    More...
RxGen, Inc. and Santaris Pharma A/S Use LNA-antimiR Technology to Antagonize the Liver-expressed microRNA-122 in Non-Human Primates and to Safely Lower Serum Cholesterol 3/27/2008 11:09:32 AM    More...
RxGen PrimaTox, Inc And BioTrove, Inc. Announce Collaboration 1/30/2006 1:46:17 PM    More...
RxGen, Inc. Announces The Formation Of RxGen PrimaTox, Inc., A Subsidiary Focused On Molecular Toxicology In Primates And Humans, Spencer Farr Named CEO 1/26/2006 11:08:44 AM    More...
RxGen, Inc. Awarded Phase I Of Fast Track SBIR For Study Of Environmental Causes Of Parkinson's Disease 10/19/2005 5:12:23 PM    More...
RxGen, Inc. Provides Preclinical Research Expertise To Support The Development Of Lipid Sciences, Inc.'s (LIPD) Delipidation Technology 10/19/2005 5:11:55 PM    More...
RxGen, Inc. Awarded $1.4 Million Fast Track SBIR For Next Generation Predictive Toxicology Program, PrimaTox 10/19/2005 5:11:45 PM    More...
RxGen, Inc. Appoints Steven R. Gullans, Former US Genomics CSO, As New Chief Executive Officer 10/19/2005 5:10:08 PM    More...
RxGen, Inc. Discovers Genes Associated With Brain Development: Discovery Provides New Insight For Treating Brain Disorders 10/19/2005 5:09:22 PM    More...

//-->